Barclays analyst Matt Miksic maintains DexCom (NASDAQ:DXCM) with a Equal-Weight and raises the price target from $103 to $110.
RBC Capital Maintains Outperform on Ally Financial, Lowers Price Target to $32
RBC Capital analyst Jon Arfstrom maintains Ally Financial (NYSE:ALLY) with a Outperform and lowers the price target from $37 to $32.